Cargando…
Therapeutic potential of targeting IL-17 and IL-23 in sepsis
Severe sepsis is a major concern of public health in industrialized countries. It is estimated that in the United States 200,000-400,000 cases occur annually and resulting in an extensive burden for the health care systems. To date, no FDA-approved pharmacologic agents for the treatment or preventio...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552565/ https://www.ncbi.nlm.nih.gov/pubmed/23369364 http://dx.doi.org/10.1186/2001-1326-1-4 |